 | Richard Naiberg at the Insight Information's Drug Patents and Legal Forum |
February-27-2008
| Lawyer | Richard Naiberg |
| Area | Health Care Law |
Details
Wednesday February 27, 2008
10:45 a.m. - 12:00 p.m: Generic's Perspective
Panelist: Richard Naiberg, Goodmans LLP
This session will focus on:
Greater availability of early dismissal motions under s. 6(5) of amended Regulations, if:
- same invalidity allegation by different generic
manufacturer was successful - patent not relevant to NOC
- patent need not be addressed, per Astra-Zeneca case
- first person evidence “speculative”
- When must a s. 6(5) motion be brought?
For more information, visit the Insight Information Website, or download the below PDF
Insight Information's Dug Patents and Legal Forum
February 27-28, 2008
St. Andrew's Club & Conference Centre
Toronto, ON
